bioRxivImmunology
Selective ablation of thymic and peripheral Foxp3+ regulatory T cell development
A. Yilmazer, D. M. Zevla, R. Malmkvist, C. A. Bello Rodriguez, P. Undurraga, E. Kirgin, M. Boernert, D. Voehringer, O. Kershaw, S. Schlenner, K. Kretschmer
Abstract
Foxp3+ Treg cells of thymic (tTreg) and peripheral (pTreg) developmental origin are thought to synergistically act to ensure immune homeostasis, with self-reactive tTreg cells primarily constraining autoimmune responses. We exploited tTreg-specific GFP/Cre recombinase activity to selectively ablate either tTreg ({Delta}tTreg) or pTreg ({Delta}pTreg) cell development. In contrast to the tTreg cell behavior in {Delta}pTreg mice, pTreg cells with a highly activated suppressor phenotype replenished the Treg cell pool of C57BL/6.{Delta}tTreg mice, preventing early mortality and fatal autoimmunity. Even with advancing age, pTreg cells largely maintained immune tolerance in C57BL/6.{Delta}tTreg mice. However, only two generations of (C57BL/6>NOD) backcrossing precipitated severe disease lethality associated with a distinct, partially overlapping pattern of organ-specific autoimmunity. Genetic association studies defined a small set of autoimmune risk loci sufficient to unleash a particularly severe form of diabetes, including genes known to impinge on Treg cell biology. Thus, pTreg cells exhibit an unexpectedly high functional adaptability, emphasizing their importance as mediators of bystander effects to ensure self-tolerance. SUMMARYThis study in complementary loss-of-function mouse models uncovers an unexpected functional plasticity of pTreg cells in constraining systemic autoimmune responses in the absence of tTreg cells and identifies tTreg cells as primary regulators of {beta}-cell autoimmunity in type 1 diabetes.
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Peripherally-induced regulatory T cells contribute to the control of autoimmune diabetes
C. Schuster, F. Zhao, S. Kissler·bioRxiv·Oct 7, 2017
- Thymically-derived Foxp3+ regulatory T cells are the primary regulators of type 1 diabetes in the non-obese diabetic mouse model
D. R. Holohan, F. Van Gool, J. A. Bluestone·bioRxiv·May 20, 2019
- Loss of FOXP3 function causes expansion of two pools of autoreactive T cells in patients with IPEX syndrome.
S. Borna, E. Lee, … R. Bacchetta·bioRxiv·Jul 10, 2022
- Activated PI3Kδ specifically perturbs mouse Treg homeostasis and function leading to immune dysregulation
A. K. Singh, F. Al Qureshah, … D. J. Rawlings·bioRxiv·Dec 21, 2023
- Loss of TET proteins in regulatory T cells unleashes effector function
X. Yue, C.-W. J. Lio, … A. Rao·bioRxiv·Feb 15, 2019
- A linear ontogeny accounts for the development of naive, memory and tumour-infiltrating regulatory T cells in mice
Sanmoy Pathak, Thea V. Hogan, … Benedict P. Seddon·Science ImmunologyPeer-reviewed·Jun 20, 2025